Literature DB >> 18837700

Clinical analyses of atopic dermatitis in the aged.

Ryoji Tanei1, Kensei Katsuoka.   

Abstract

The aim of the present study was to analyze the characteristics of atopic dermatitis (AD) in the senile phase. Subjects were comprised of 16 patients investigated for clinical features, serum immunoglobulin (Ig)E levels and skin manifestations. Mean age was 76.9 +/- 6.2 years (range, 68-87), with a man : woman ratio of 3:1. Mean age at onset was 67.7 +/- 15.7 years. Eight patients (50%) had personal histories of chronic eczema until the young adult phase and three patients (18.8%) showed the classic course of child AD. Eczematous erythroderma in 10 patients (62.5%) and unclassified chronic eczema in five patients (31.3%) were the predominant clinical presentations. Mean total IgE level in sera of the 16 patients was 8810 +/- 13 511 IU/mL (range, 5-53 605). Fourteen patients showed positive results for antigen-specific IgE antibodies, and the mean total IgE level for these patients was 10 056 +/- 14 044 IU/mL. Specific IgE to the main antigen, Dermatophagoides farinae, was observed in 12 patients (85.7%), representing the principal antibody in eight patients (57.1%). Eczematous dermatitis manifested predominantly in the face and neck, trunk and extensor and flexure sites of extremities, and less commonly in the antecubital and popliteal areas. Other stigmata of AD were observed as follows: red face in 10 patients (62.5%); Hertoghe's sign in six (37.5%); goose-skin in four (25%); facial pallor in three (18.8%); and dirty neck in one (6.3%). These results indicate that senile-type AD represents a characteristic subgroup of AD that appears in the last stage of life in AD patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18837700     DOI: 10.1111/j.1346-8138.2008.00524.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  7 in total

1.  Analysis of MAST-CLA Results as a Diagnostic Tool in Allergic Skin Diseases.

Authors:  Jung Won Shin; Seon-Pil Jin; Jong Hee Lee; Soyun Cho
Journal:  Ann Dermatol       Date:  2010-02-28       Impact factor: 1.444

Review 2.  Molecular biology of atopic dermatitis.

Authors:  Zhanglei Mu; Yan Zhao; Xiaojing Liu; Christopher Chang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 3.  Influences of Environmental Chemicals on Atopic Dermatitis.

Authors:  Kwangmi Kim
Journal:  Toxicol Res       Date:  2015-06

4.  Abundant immunoglobulin E-positive cells in skin lesions support an allergic etiology of atopic dermatitis in the elderly.

Authors:  R Tanei; Y Hasegawa; M Sawabe
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-06-15       Impact factor: 6.166

5.  Nomenclature and clinical phenotypes of atopic dermatitis.

Authors:  Giampiero Girolomoni; Marjolein de Bruin-Weller; Valeria Aoki; Kenji Kabashima; Mette Deleuran; Luis Puig; Ashish Bansal; Ana B Rossi
Journal:  Ther Adv Chronic Dis       Date:  2021-03-26       Impact factor: 5.091

6.  Clinical Characteristics, Treatments, and Prognosis of Atopic Eczema in the Elderly.

Authors:  Ryoji Tanei
Journal:  J Clin Med       Date:  2015-05-18       Impact factor: 4.241

Review 7.  Atopic Dermatitis in Older Adults: A Review of Treatment Options.

Authors:  Ryoji Tanei
Journal:  Drugs Aging       Date:  2020-03       Impact factor: 3.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.